Global Oncology Radiopharmaceutical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oncology Radiopharmaceutical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oncology Radiopharmaceutical report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oncology Radiopharmaceutical market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics and Pharmaceutical Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oncology Radiopharmaceutical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oncology Radiopharmaceutical key manufacturers include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc. Novartis, Chimeric Therapeutics Limited, Fusion Pharma are top 3 players and held % sales share in total in 2022.
Oncology Radiopharmaceutical can be divided into Oral Drugs, Intravenous Drugs and Other,, etc. Oral Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Oncology Radiopharmaceutical is widely used in various fields, such as Hospitals and Clinics, Pharmaceutical Company, Research Center and Other, etc. Hospitals and Clinics provides greatest supports to the Oncology Radiopharmaceutical industry development. In 2022, global % sales of Oncology Radiopharmaceutical went into Hospitals and Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oncology Radiopharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Segment by Type
Oral Drugs
Intravenous Drugs
Other
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oncology Radiopharmaceutical market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oncology Radiopharmaceutical, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oncology Radiopharmaceutical industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oncology Radiopharmaceutical in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oncology Radiopharmaceutical introduction, etc. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oncology Radiopharmaceutical market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Oncology Radiopharmaceutical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oncology Radiopharmaceutical key manufacturers include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc. Novartis, Chimeric Therapeutics Limited, Fusion Pharma are top 3 players and held % sales share in total in 2022.
Oncology Radiopharmaceutical can be divided into Oral Drugs, Intravenous Drugs and Other,, etc. Oral Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Oncology Radiopharmaceutical is widely used in various fields, such as Hospitals and Clinics, Pharmaceutical Company, Research Center and Other, etc. Hospitals and Clinics provides greatest supports to the Oncology Radiopharmaceutical industry development. In 2022, global % sales of Oncology Radiopharmaceutical went into Hospitals and Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oncology Radiopharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Segment by Type
Oral Drugs
Intravenous Drugs
Other
Segment by Application
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oncology Radiopharmaceutical market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oncology Radiopharmaceutical, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oncology Radiopharmaceutical industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oncology Radiopharmaceutical in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oncology Radiopharmaceutical introduction, etc. Oncology Radiopharmaceutical Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oncology Radiopharmaceutical market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices